KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Current Assets (2016 - 2025)

Historic Current Assets for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $24.8 billion.

  • Abbott Laboratories' Current Assets rose 435.68% to $24.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $24.8 billion, marking a year-over-year increase of 435.68%. This contributed to the annual value of $23.7 billion for FY2024, which is 434.94% up from last year.
  • Abbott Laboratories' Current Assets amounted to $24.8 billion in Q3 2025, which was up 435.68% from $24.5 billion recorded in Q2 2025.
  • Abbott Laboratories' 5-year Current Assets high stood at $25.2 billion for Q4 2022, and its period low was $21.8 billion during Q1 2021.
  • For the 5-year period, Abbott Laboratories' Current Assets averaged around $23.6 billion, with its median value being $23.5 billion (2023).
  • In the last 5 years, Abbott Laboratories' Current Assets skyrocketed by 4077.3% in 2021 and then tumbled by 1012.53% in 2023.
  • Quarter analysis of 5 years shows Abbott Laboratories' Current Assets stood at $24.2 billion in 2021, then increased by 4.06% to $25.2 billion in 2022, then fell by 10.13% to $22.7 billion in 2023, then rose by 4.35% to $23.7 billion in 2024, then increased by 5.0% to $24.8 billion in 2025.
  • Its last three reported values are $24.8 billion in Q3 2025, $24.5 billion for Q2 2025, and $23.2 billion during Q1 2025.